Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year revenue growth rate
Latest
420.00%
↓ 88% vs avg
Percentile
P90
Near historical high
Streak
1 qtr
Consecutive growthDecelerating
Average
3603.76%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 420.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -86.49% |
| Q4 2023 | -89.78% |
| Q3 2023 | 5933.33% |
| Q2 2023 | -71.43% |
| Q1 2023 | 119.09% |
| Q4 2022 | -5600.00% |
| Q3 2022 | -75.00% |
| Q2 2022 | -75.00% |
| Q1 2022 | -99.02% |
| Q4 2021 | 1974.05% |
| Q3 2021 | 15.33% |
| Q2 2021 | -83.65% |
| Q1 2021 | -63.77% |
| Q4 2020 | -21.28% |
| Q3 2020 | 307.13% |
| Q2 2020 | -67.39% |
| Q1 2020 | 284.28% |
| Q4 2019 | -10.59% |
| Q3 2019 | -60.40% |
| Q2 2019 | -44.98% |
| Q1 2019 | 14.17% |
| Q4 2018 | -1.74% |
| Q3 2018 | 8.99% |
| Q2 2018 | 48849.78% |
| Q1 2018 | -99.82% |
| Q4 2017 | -38.83% |
| Q3 2017 | 92891.90% |
| Q2 2017 | -99.39% |
| Q1 2017 | -28.17% |
| Q4 2016 | 12.63% |
| Q3 2016 | -52.92% |
| Q2 2016 | 109.93% |
| Q1 2016 | -20.59% |